-
Yasuhiro Ito
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Clinical Trial Management Center, Department of Surgery, Kuma Hospital, Kobe, Japan
-
Shinichi Suzuki
Chairperson of Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Department of Thyroid and Endocrinology, Fukushima Medical University School of Medicine, Fukushima, Japan
-
Ken-ichi Ito
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Division of Breast, Endocrine and Respiratory Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan
-
Tsuneo Imai
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan National Hospital Organization, Higashinagoya National Hospital, Nagoya, Japan
-
Takahiro Okamoto
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Department of Surgery II, Tokyo Women’s Medical University, Tokyo, Japan
-
Hiroya Kitano
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Department of Otolaryngology, Tottori University School of Medicine, Yonago, Japan
-
Iwao Sugitani
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Department of Endocrine Surgery, Nippon Medical School, Tokyo, Japan
-
Kiminori Sugino
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Department of Surgery, Ito Hospital, Tokyo, Japan
-
Hidemitsu Tsutsui
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Department of Chest and Thyroid Surgery, Tokyo Medical University, Tokyo, Japan
-
Hisato Hara
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Department of Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan
-
Akira Yoshida
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Kanagawa Health Service Association, Yokohama, Japan
-
Kazuo Shimizu
Committee of Pharmacological Therapy for Thyroid Cancer of Japan Association of Endocrine Surgery (JAES) and Japanese Society of Thyroid Surgery (JSTS), Japan Department of Endocrine Surgery, Nippon Medical School, Tokyo, Japan